文献速递银屑病与炎症性皮肤病

微透析代谢组与蛋白质组分析揭示银屑病疾病严重程度的特征性变化

Microdialysis-based metabolomic and proteomic profiling reveals signature variations for disease severity in psoriasis.
PubMed 文献 · J Invest Dermatol · 2026-06-10

本研究对银屑病患者皮损与非皮损部位及健康对照的皮肤微透析液进行非靶向蛋白质组与代谢组分析,发现皮损具有独特分子特征并按疾病严重程度分离,涉及促炎蛋白、嘌呤/嘧啶代谢物及多胺升高;系统治疗应答者皮损代谢谱正常化,提示微透析分析可用于追踪疗效。

要点

  • 微透析可微创采样完整皮肤可溶性介质,适合重复监测。
  • 银屑病皮损蛋白质与代谢谱随疾病严重程度分离。
  • 系统治疗应答者皮损代谢谱可正常化。

核心结论

  • 皮肤微透析液蛋白质组与代谢组分析可揭示银屑病皮损的局部病理生理特征,并有望用于监测疾病严重程度与治疗反应。

研究设计与样本

  • 对银屑病患者皮损与非皮损部位及健康对照的皮肤微透析液进行非靶向蛋白质组与代谢组分析。

主要发现

  • 主成分分析显示银屑病皮损具有独特分子特征,并按疾病严重程度分离。
  • 皮损中促炎蛋白(SERPINB3/4、FABP5)、嘌呤与嘧啶代谢物(腺苷-5-单磷酸、5'-胞苷单磷酸)及多胺(亚精胺、精胺)升高。
  • 通路分析证实核苷酸代谢与多胺生物合成上调,组氨酸代谢降低。
  • 系统治疗应答者的皮损代谢组谱正常化。

临床怎么用

  • 微透析液蛋白质组与代谢组分析可作为银屑病微创监测平台,用于机制研究、生物标志物发现及个体化监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Psoriasis is a common chronic inflammatory skin disease characterized by epidermal hyperproliferation and immune dysregulation. However, local metabolic interactions remain incompletely understood, and biomarkers for disease activity and treatment response are still lacking. Current approaches such as skin biopsies or tape stripping are disruptive to the skin barrier and may cause scarring, limiting their repeated use. In contrast, microdialysis enables minimally invasive sampling of soluble mediators from intact skin. We applied untargeted proteomic and metabolomic profiling of skin microdialysates from lesional and nonlesional sites in patients with psoriasis and healthy controls to explore local pathophysiology and evaluate this technique's potential for monitoring disease severity and treatment response. Principal component analysis revealed distinct molecular signatures in psoriatic lesions, with separation by disease severity, resulting from elevated proinflammatory proteins (SERPINB3/4, FABP5), purine and pyrimidine metabolites (adenosine-5-monophosphate, 5'-cytidine monophosphate) and polyamines (spermidine and spermine). Pathway analysis confirmed upregulated nucleotide metabolism and polyamine biosynthesis alongside reduced histidine metabolism, consistent with hyperproliferation, immune activation, and barrier disruption. Importantly, lesional metabolomic profiles normalized in patients responding to systemic therapy, highlighting the utility of microdialysate profiling for tracking therapeutic efficacy. This study establishes microdialysate proteometabolomics as a minimally invasive platform for mechanistic studies, biomarker discovery, and personalized monitoring in psoriasis.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Gross L, Buddenkotte J, Joy F, et al. Microdialysis-based metabolomic and proteomic profiling reveals signature variations for disease severity in psoriasis. J Invest Dermatol. 2026. PMID: 42274453. doi:10.1016/j.jid.2026.04.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。